Basket | Login


Achim Schneeberger


Prof. Schneeberger currently serves as Chief Medical Officer at AFFiRiS AG, one of Austria’s leading biotechnology companies. He has acquired extensive experience in biomedical research, clinical dermatology and immunotherapy of cancer and chronic diseases. He studied Medicine at the University of Tübingen, Germany and the University of Bordeaux II, France. Achim Schneeberger carried out his postdoctoral research at the Department of Dermatology at the Medical University of Vienna, Austria. There, he also received his training in Dermatology. At the time he was not only doing basic science, but was also instrumental in translating his research on melanoma vaccines to the clinical setting. He received several prizes including the thesis award from the Medical University of Tübingen and the Egner Dermatooncology Prize from the German Dermatological Research Society. In 2005, Dr. Schneeberger joined the Laboratory of Prof. Yokoyama at Washington University, Saint Louis, Missouri, to study the interactions between NK cells and cancer. Upon returning to Europe, Prof. Schneeberger joined AFFiRiS to build and lead the clinical research department. As CMO, he is responsible for the clinical development of the company’s vaccine candidates, in particular those in the fields of Alzheimer’s disease, Parkinson’s disease and Atherosclerosis.



Last Updated: Friday 11 January 2013